Veterinary drug for dogs and cats.
Indications
Wormax 10 Flavour by Ecuphar is indicated in dogs and cats for the control and treatment of infections caused by nematodes and tapeworms; in particular the mature and immature forms of the following parasites. Ascarids: Toxocara canis, Toxascaris leonina. Hookworms: Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma tubaeforme. Whipworms: Trichuris vulpis. Tapeworms: Echinococcusgranulosus, E. multilocularis, Dipylidium caninum, Taenia spp, Multiceps multiceps, Mesocestoides spp. In dogs indicated for the treatment of infections caused by, Protozoa: Giardia spp.
Composition
Active ingredients
One 624 mg tablet contains, active ingredients: praziquantel 50 mg; fenbendazole 500 mg.
Excipients
Polyvinylpyrrolidone, magnesium stearate, sodium lauryl sulfate, croscarmellose sodium, meat flavor.
Directions for use and Dosage
To ensure administration of the correct dose, body weight must be determined as accurately as possible. The recommended dose is 5 mg/kg of praziquantel and 50 mg/kg of fenbendazole equal to 1 tablet for every 10 kg of live weight. Indicative dosage. Dogs, puppies and small dogs. Dog weight: half a kg - 2 kg b.w., one quarter of a tablet. Dog weight: 2 - 5 kg b.w., half a tablet. Dog weight: 5 - 10 kg b.w., 1 tablet. Cats: kittens, one quarter of a tablet. Adult cats up to 5 kg, half a tablet. Adult cats over 5 kg, 1 tablet. Administer the tablet directly into the mouth or, if necessary, mix it with the preferred food. Always check that the medicine has been taken. In the case of severe infections, repeat the treatment after 24 hours. No purging, fasting, or other special measures are necessary to ensure the product's effectiveness. For the treatment of Giardia spp. in dogs, administer for three consecutive days.
Warnings
Be careful to avoid the following practices because they may cause serious infections. may increase the risk of developing resistance and could ultimately lead to ineffective therapy: excessively frequent and repeated use of anthelmintics of the same class over a prolonged period of time; underdosing, due to incorrect body weight estimation, failure to administer the product, or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be verified using appropriate tests (e.g., Fecal Egg Reduction Test). When test results confirm resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. The selection of key resistance genes that lead to the development of resistance may be a key factor in the development of resistance. lead to ineffective anthelmintic therapy.
Special precautions for use in animals: Do not administer the product during the first 4 weeks of pregnancy.
Special precautions to be taken by the person administering the veterinary medicinal product to animals: Wash hands after use.
Avoid contact with eyes. In case of eye irritation, seek medical advice. Do not eat, drink or smoke while using the product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label. To avoid contamination, destroy faeces passed within 24 hours of treatment.
Other precautions: The veterinary medicinal product is effective against Echinococcus spp., which is not present in all European countries but is becoming increasingly common. Echinococcosis represents a danger to humans. Since echinococcosis is a disease known to the World Organisation for Animal Health (OIE), specific guidelines on treatment and control, and on the protection of people, must be provided by the relevant competent authorities.
Contraindications
Do not administer the product during the first 4 weeks of pregnancy. Do not use in animals with known hypersensitivity to the active substances or to any of the excipients.
Side effects
Animals treated with high doses, cats in particular, may experience episodes of vomiting and diarrhea. However, the symptoms resolve spontaneously. The frequency of adverse reactions is defined using the following conventions: very common (more than 1 in 10 animals treated displaying adverse reactions); common (more than 1 but less than 10 animals in 100 animals treated); uncommon (more than 1 but less than 10 animals in 1,000 animals treated); rare (more than 1 but less than 10 animals in 10,000 animals treated); very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Overdose
In case of overdose (doses up to 5 times higher than those recommended), episodes of vomiting and diarrhoea which regress spontaneously may occur, especially in cats. Main incompatibilities: not applicable.
Storage
Do not store above 25 degrees C. Keep the blister in the original packaging in order to protect it from light and moisture. Shelf life of the veterinary medicinal product as packaged for sale: 48 months. Any remaining tablet fractions should be consumed immediately and not stored.
Format
3 Tablets
Product Code:FRCM216201
Richiedi info sul prodotto
